Kathrin Arndt

MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia

Yufei Chen, Konstantinos Anastassiadis, Andrea Kranz et al. · Cancer Cell · 2017 · 91 citations · Full text

Hematological Malignancy, Major Role, Mixed-phenotype Acute Leukemia +8

Clonal expansion capacity defines two consecutive developmental stages of long-term hematopoietic stem cells

Tatyana Grinenko, Kathrin Arndt, Melanie Portz et al. · The Journal of Experimental Medicine · 2014 · 82 citations · Full text

Clonal Expansion Capacity, Developmental Biology, Transplantation +15

SETD1A protects HSCs from activation-induced functional decline in vivo

Kathrin Arndt, Andrea Kranz, Juliane Fohgrub et al. · Blood · 2018 · 67 citations

CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells

Kathrin Arndt, Tatyana Grinenko, Nicole Mende et al. · Proceedings of the National Academy of Sciences · 2013 · 47 citations · Full text

Cell Therapy, Developmental Biology, Steady State +15

Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation

Eva‐Maria Willing, Claudia Vollbrecht, Christine Vössing et al. · Cancers · 2023 · 25 citations · Full text